Observational study to assess clinical outcomes and patient satisfaction after multifocal IOL implantatio
- Conditions
- patient satisfaction after implantation of a multi-focal IO
- Registration Number
- DRKS00010108
- Lead Sponsor
- Optana GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 28
Patients must have read, understood and signed the Patient Information (Informed Consent Form)
Patients that underwent uneventful refractive surgery (LASIK, PRK) after cataract surgery can be included
Only patients that underwent uneventful cataract surgery with a bilateral implantation of multifocal IO
Existing posterior capsule opacity (PCO) at the day of study examination
The time between the surgeries of both eyes is maximum 3 months
Clinically significant glaucoma
Clinically significant macular degeneration, clinically significant macular edema or proliferative diabetic retinopathy
Patients with keratoconus or keratectasia
Patients who are pregnant or nursing
Abnormal examination results from slit lamp, fundus examination or IOL Master, topography, age related changes are acceptable
Patients who do not give informed consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mesopic constrast sensitivity 6-24 months post-op
- Secondary Outcome Measures
Name Time Method patient satisfaction is determined 6-24 months post-op using the VFQ-25